Cannabidiol Compared to Pharmacological Treatment as Usual for Crack Use Disorder: A Feasibility, Preliminary Efficacy, Parallel, Double-Blind, Randomized Clinical Trial.

Cannabidiol (CBD) has been studied for substance use disorders treatment due to its anxiolytic effects, for sleep, appetite, reduction of craving, and maintenance of abstinence. The study aims to assess CBD's feasibility, safety/tolerability, and preliminary efficacy compared to pharmacological trea...

Descripción completa

Detalles Bibliográficos

Publicado en:	International Journal of Mental Health & Addiction Vol. 23; no. 4; pp. 3222 - 3247
Autores principales:	Gallassi, Andrea Donatti, de Oliveira, André Wagner Carvalho, Rodrigues, Larissa Alencar, Nakano, Eduardo Yoshio, Ruas, Pedro A. S., de La Mata, José Antonio Iturri, Júnior, Ettore Ferrari, de Andrade Gomes, Juliano, Caroba, Mariana Emanuele Silva, dos Santos Silva, Marianna Gabriella, Vieira, Mariana G. Q., Reis, Julia G. G. R., Leite, Jade Luiza Moreira, de Lima, Guilherme Henrique Alves, Lima, Jonathan Morais, Lima, Yasmim P. V., Ribas, Jorge A. A., das Chagas, Nathalia A. L., Magalhães, Mateus A., da Silva, Mateus F.
Formato:	Case Study
Publicado:	Springer Nature Aug2025
Materias:	Clinical trials Randomized controlled trials Cocaine abuse Substance-induced disorders Cannabidiol Treatment effectiveness Safety Adverse health care events
Acceso en línea:	Ver este registro en EBSCOhost